| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 8 |
| NetGPI | no | yes: 0, no: 8 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A0A3S7WXT4
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.276 |
| CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.276 |
| CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.252 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.511 |
| DOC_CYCLIN_RxL_1 | 41 | 48 | PF00134 | 0.445 |
| DOC_CYCLIN_yClb1_LxF_4 | 75 | 81 | PF00134 | 0.254 |
| LIG_14-3-3_CanoR_1 | 97 | 107 | PF00244 | 0.434 |
| LIG_Actin_WH2_2 | 50 | 66 | PF00022 | 0.279 |
| LIG_BRCT_BRCA1_1 | 55 | 59 | PF00533 | 0.254 |
| LIG_BRCT_BRCA1_1 | 76 | 80 | PF00533 | 0.254 |
| LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.547 |
| LIG_EH1_1 | 79 | 87 | PF00400 | 0.314 |
| LIG_FHA_1 | 13 | 19 | PF00498 | 0.426 |
| LIG_FHA_1 | 46 | 52 | PF00498 | 0.282 |
| LIG_NRBOX | 6 | 12 | PF00104 | 0.507 |
| LIG_RPA_C_Fungi | 94 | 106 | PF08784 | 0.346 |
| LIG_SH2_STAP1 | 116 | 120 | PF00017 | 0.428 |
| LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.287 |
| LIG_SH3_3 | 11 | 17 | PF00018 | 0.410 |
| LIG_SH3_3 | 37 | 43 | PF00018 | 0.280 |
| LIG_SUMO_SIM_anti_2 | 3 | 8 | PF11976 | 0.280 |
| LIG_SUMO_SIM_anti_2 | 87 | 93 | PF11976 | 0.346 |
| LIG_SUMO_SIM_par_1 | 105 | 111 | PF11976 | 0.314 |
| MOD_CK1_1 | 28 | 34 | PF00069 | 0.286 |
| MOD_CK1_1 | 69 | 75 | PF00069 | 0.377 |
| MOD_CK2_1 | 59 | 65 | PF00069 | 0.339 |
| MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.529 |
| MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.281 |
| MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.342 |
| MOD_GSK3_1 | 108 | 115 | PF00069 | 0.370 |
| MOD_GSK3_1 | 76 | 83 | PF00069 | 0.265 |
| MOD_N-GLC_1 | 51 | 56 | PF02516 | 0.314 |
| MOD_NEK2_1 | 108 | 113 | PF00069 | 0.337 |
| MOD_NEK2_1 | 26 | 31 | PF00069 | 0.383 |
| MOD_NEK2_1 | 53 | 58 | PF00069 | 0.254 |
| MOD_NEK2_1 | 59 | 64 | PF00069 | 0.254 |
| MOD_NEK2_1 | 80 | 85 | PF00069 | 0.268 |
| MOD_PIKK_1 | 45 | 51 | PF00454 | 0.245 |
| MOD_PKA_2 | 98 | 104 | PF00069 | 0.290 |
| MOD_Plk_1 | 66 | 72 | PF00069 | 0.339 |
| MOD_Plk_4 | 53 | 59 | PF00069 | 0.324 |
| MOD_Plk_4 | 69 | 75 | PF00069 | 0.290 |
| MOD_Plk_4 | 76 | 82 | PF00069 | 0.253 |
| MOD_Plk_4 | 84 | 90 | PF00069 | 0.196 |
| TRG_DiLeu_BaLyEn_6 | 14 | 19 | PF01217 | 0.254 |
| TRG_ER_diArg_1 | 40 | 42 | PF00400 | 0.339 |
| TRG_ER_diArg_1 | 96 | 99 | PF00400 | 0.280 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0S4IWN9 | Bodo saltans | 61% | 100% |
| A0A1X0NYC0 | Trypanosomatidae | 66% | 96% |
| A0A422N7S4 | Trypanosoma rangeli | 62% | 99% |
| A0NGI1 | Anopheles gambiae | 33% | 86% |
| A4HCY9 | Leishmania braziliensis | 88% | 100% |
| A4I0H4 | Leishmania infantum | 100% | 100% |
| A7YW81 | Bos taurus | 30% | 86% |
| C9ZV99 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 100% |
| Q4QB36 | Leishmania major | 96% | 100% |
| Q54ZG7 | Dictyostelium discoideum | 40% | 95% |
| Q8R1E7 | Mus musculus | 30% | 86% |
| Q8WY98 | Homo sapiens | 30% | 74% |